Leerink Swann Starts Hyperion Therapeutics (HPTX) at Outperform; Attractive Opportunity in Orphan Drug Model

Go back to Leerink Swann Starts Hyperion Therapeutics (HPTX) at Outperform; Attractive Opportunity in Orphan Drug Model
HYPERION THPTCS (NASDAQ: HPTX) Delayed: 45.99 --0 (-0%)
Previous Close $45.99    52 Week High $46.96 
Open $1.29    52 Week Low $20.23 
Day High $45.99    P/E 22.54 
Day Low $45.99    EPS $2.04 
Volume 485,726       

Medicis Pharmaceutical Corp. (NASDAQ: MRX) Delayed: 71.06 -1.3 (1.8%)
Previous Close $72.36    52 Week High $44.00 
Open $72.37    52 Week Low $30.30 
Day High $72.37    P/E 102.99 
Day Low $69.43    EPS $0.69 
Volume 815,365       

Salix Pharmaceuticals Ltd (NASDAQ: SLXP) Delayed: 172.81 --0 (-0%)
Previous Close $172.81    52 Week High $172.98 
Open $0.00    52 Week Low $86.00 
Day High $172.81    P/E 104.10 
Day Low $172.81    EPS $1.66 
Volume 28,701